Lantern Pharma
LTRN
LTRN
30 hedge funds and large institutions have $9.89M invested in Lantern Pharma in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
12% less funds holding
Funds holding: 34 → 30 (-4)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Holders
30
Holding in Top 10
1
Calls
$102K
Puts
$16K
Top Buyers
| 1 | +$170K | |
| 2 | +$109K | |
| 3 | +$88.4K | |
| 4 |
Two Sigma Investments
New York
|
+$69.8K |
| 5 |
Renaissance Technologies
New York
|
+$41.3K |
Top Sellers
| 1 | -$262K | |
| 2 | -$40.1K | |
| 3 | -$39.9K | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$14.2K |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
-$8.63K |
